Literature DB >> 19333723

Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX.

Fatemeh Mosaffa1, Hermann Lage, Jalil Tavakol Afshari, Javad Behravan.   

Abstract

OBJECTIVE: In this study, we aimed to evaluate the influence of proinflammatory cytokines on ABCG2 expression and function in human MCF-7 breast cancer cell line and its mitoxantrone-resistant derivative MCF-7/MX.
METHODS: The effects of proinflammatory cytokines on ABCG2 mRNA expression were studied using real-time PCR method. Cytokine-mediated modification of ABCG2 protein expression and function was investigated by means of flow cytometry.
RESULTS: Significant inductions in the ABCG2 mRNA levels, protein expression, and activity were observed in IL-1 beta and TNF-alpha-treated MCF-7 cells. IL-6 increased ABCG2 protein, but had no effects on ABCG2 mRNA and function in MCF-7 cells. Although IL-1 beta did not alter mRNA and protein levels of the transporter in MCF-7/MX cells, ABCG2-mediated efflux was significantly increased in IL-1 beta-treated MCF-7/MX cells. TNF-alpha-treated MCF-7/MX cells also demonstrated greater ABCG2 protein expression and function without any changes in mRNA levels of the transporter. Neither ABCG2 mRNA nor its protein expression and function were affected by IL-6 in MCF-7/MX cells.
CONCLUSION: IL-1 beta and TNF-alpha induce ABCG2 mRNA and protein expression and increase its activity in breast cancer cell line MCF-7. In MCF-7/MX cells these cytokines modulate ABCG2 protein expression and/or function, but they have no influence on the transporter mRNA levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333723     DOI: 10.1007/s00011-009-0034-6

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  40 in total

1.  Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.

Authors:  Stefan Buchholz; Gunhild Keller; Andrew V Schally; Gabor Halmos; Florian Hohla; Elmar Heinrich; Frank Koester; Benjamin Baker; Jörg B Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

2.  Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.

Authors:  U Stein; W Walther; C M Laurencot; G L Scheffer; R J Scheper; R H Shoemaker
Journal:  J Natl Cancer Inst       Date:  1997-06-04       Impact factor: 13.506

3.  Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes.

Authors:  M Sukhai; A Yong; A Pak; M Piquette-Miller
Journal:  Inflamm Res       Date:  2001-07       Impact factor: 4.575

4.  Expression of interleukin-1beta in human breast carcinoma.

Authors:  L Jin; R Q Yuan; A Fuchs; Y Yao; A Joseph; R Schwall; S J Schnitt; A Guida; H M Hastings; J Andres; G Turkel; P J Polverini; I D Goldberg; E M Rosen
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

5.  Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis.

Authors:  Christian Zimmermann; Petr Hruz; Heike Gutmann; Luigi Terracciano; Ulrich Beuers; Frank Lehmann; Christoph Beglinger; Juergen Drewe
Journal:  Digestion       Date:  2006-12-07       Impact factor: 3.216

6.  Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.

Authors:  B Ogretmen; A R Safa
Journal:  Biochemistry       Date:  1999-02-16       Impact factor: 3.162

7.  Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation.

Authors:  M Piquette-Miller; A Pak; H Kim; R Anari; A Shahzamani
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

8.  Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures.

Authors:  K I Hirsch-Ernst; C Ziemann; H Foth; D Kozian; C Schmitz-Salue; G F Kahl
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

9.  Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue.

Authors:  D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

10.  Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.

Authors:  David Théron; Sylvie Barraud de Lagerie; Sylviane Tardivel; Hélène Pélerin; Philippe Demeuse; Claire Mercier; Aloïse Mabondzo; Robert Farinotti; Bernard Lacour; Françoise Roux; François Gimenez
Journal:  Biochem Pharmacol       Date:  2003-08-15       Impact factor: 5.858

View more
  19 in total

Review 1.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

3.  Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells.

Authors:  Erin C Tracy; Mary J Bowman; Ravindra K Pandey; Barbara W Henderson; Heinz Baumann
Journal:  Photochem Photobiol       Date:  2011-10-03       Impact factor: 3.421

Review 4.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

5.  Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.

Authors:  Fatemeh Mosaffa; Fatemeh Kalalinia; Herman Lage; Jalil Tavakol Afshari; Javad Behravan
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

6.  Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.

Authors:  Madhumita Pradhan; Leslie A Bembinster; Sarah C Baumgarten; Jonna Frasor
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

7.  Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Anika L Dzierlenga; John D Clarke; Michael J Goedken; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-12-08       Impact factor: 3.922

Review 8.  The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches.

Authors:  Daniel Cruceriu; Oana Baldasici; Ovidiu Balacescu; Ioana Berindan-Neagoe
Journal:  Cell Oncol (Dordr)       Date:  2020-01-03       Impact factor: 6.730

9.  Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.

Authors:  Mahnaz Nourbakhsh; Mahmoud Reza Jaafari; Hermann Lage; Khalil Abnous; Fatemeh Mosaffa; Ali Badiee; Javad Behravan
Journal:  Iran J Basic Med Sci       Date:  2015-04       Impact factor: 2.699

10.  Expression of Drug Pump Protein MRP2 in Lipopolysaccharide-Treated Rats and its Impact on the Disposition of Acetaminophen.

Authors:  Mitra Hassany; Mohammad Hassanzadeh Khayat; Javaad Behravan; Jamaal Kasaeeian
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.